This site is intended for Healthcare Professionals only

You’re doing great.  (0% complete)

quiz close icon

module menu icon New medicines continued

  • Soolantra cream, containing ivermectin, for the treatment of inflammatory rosacea lesions
  • Xadago, containing safinamide, for add-on treatment to levodopa in mid- to late-stage fluctuating idiopathic PD
  • Fiasp (insulin aspart) in vials, cartridges and pens for diabetes
  • Espranor, comprising buprenorphine in oral lyophilisate form, for substitution treatment for opioid dependence
  • Mysimba, a weight management product containing naltrexone and bupropion
  • Truberzi tablets containing eluxadoline, for the treatment of IBS with diarrhoea
  • Rupatadine tablets, a second generation antihistamine for the symptomatic treatment of allergic rhinitis and urticaria.
  • Details of new medicines – many of which are black triangle drugs, subject to additional monitoring for quick identification of safety information – can be found via the electronic Medicines Compendium (eMC)

    Change privacy settings